EICHORCondition: Secondary Hyperparathyroidism Due to Renal Causes · Chronic Kidney Diseases · Vitamin D Deficiency · Sponsor: OPKO Health, Inc.
Safety, Efficacy, PK and PD of CTAP101 (calcifediol) ER Capsules for SHPT in HD Patients VDI
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| AKDHC Medical Research Services | Peoria, Arizona, United States | — |
| AKDHC Medical Research Services | Phoenix, Arizona, United States | — |
| AKDHC Medical Research Services | Phoenix, Arizona, United States | — |
| AKDHC Medical Research Services | Phoenix, Arizona, United States | — |
| WCCT Global, Inc. | Cypress, California, United States | — |
| Hacienda Dialysis Center | Hacienda Heights, California, United States | — |
| California Institute of Renal Research CKD/Dialysis & Transplant Division | La Mesa, California, United States | — |
| Long Beach Quest Dialysis Center | Long Beach, California, United States | — |
| Ontario Dialysis Center | Ontario, California, United States | — |
| North America Research Institute, Inc. | San Dimas, California, United States | — |
| Laurel Canyon Dialysis, LLC | Sun Valley, California, United States | — |
| University of Colorado Denver Anschutz Medical Campus | Aurora, Colorado, United States | — |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03602261